147 related articles for article (PubMed ID: 37027073)
1. The effects of KIR2DL4 stimulated NK-92 cells on the apoptotic pathways of HER2 + /HER-breast cancer cells.
Kilic N; Dastouri M; Kandemir I; Yilmaz E
Med Oncol; 2023 Apr; 40(5):139. PubMed ID: 37027073
[TBL] [Abstract][Full Text] [Related]
2. The apoptotic effects of NK-92 cells stimulated with an anti-CD226 antibody on MDA-MB-231 triple-negative breast cancer cells.
Dastouri M; Kilic N; Yilmaz H
Med Oncol; 2023 Jul; 40(8):228. PubMed ID: 37410214
[TBL] [Abstract][Full Text] [Related]
3. Interaction between HLA-G and NK cell receptor KIR2DL4 orchestrates HER2-positive breast cancer resistance to trastuzumab.
Zheng G; Guo Z; Li W; Xi W; Zuo B; Zhang R; Wen W; Yang AG; Jia L
Signal Transduct Target Ther; 2021 Jun; 6(1):236. PubMed ID: 34158475
[TBL] [Abstract][Full Text] [Related]
4. The Killer Cell Ig-like Receptor 2DL4 Expression in Human Mast Cells and Its Potential Role in Breast Cancer Invasion.
Ueshima C; Kataoka TR; Hirata M; Furuhata A; Suzuki E; Toi M; Tsuruyama T; Okayama Y; Haga H
Cancer Immunol Res; 2015 Aug; 3(8):871-80. PubMed ID: 25735953
[TBL] [Abstract][Full Text] [Related]
5. Actin Cytoskeleton Remodeling Drives Breast Cancer Cell Escape from Natural Killer-Mediated Cytotoxicity.
Al Absi A; Wurzer H; Guerin C; Hoffmann C; Moreau F; Mao X; Brown-Clay J; Petrolli R; Casellas CP; Dieterle M; Thiery JP; Chouaib S; Berchem G; Janji B; Thomas C
Cancer Res; 2018 Oct; 78(19):5631-5643. PubMed ID: 30104240
[TBL] [Abstract][Full Text] [Related]
6. Roles of HLA-G/KIR2DL4 in Breast Cancer Immune Microenvironment.
Zheng G; Jia L; Yang AG
Front Immunol; 2022; 13():791975. PubMed ID: 35185887
[TBL] [Abstract][Full Text] [Related]
7. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells.
Rajagopalan S; Long EO
J Exp Med; 1999 Apr; 189(7):1093-100. PubMed ID: 10190900
[TBL] [Abstract][Full Text] [Related]
8. KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential.
Faure M; Long EO
J Immunol; 2002 Jun; 168(12):6208-14. PubMed ID: 12055234
[TBL] [Abstract][Full Text] [Related]
9. Effects of ADAM10 and ADAM17 Inhibitors on Natural Killer Cell Expansion and Antibody-dependent Cellular Cytotoxicity Against Breast Cancer Cells
Pham DH; Kim JS; Kim SK; Shin DJ; Uong NT; Hyun H; Yoon MS; Kang SJ; Ryu YJ; Cho JS; Yoon JH; Lee JS; Cho D; Lee SH; Park MH
Anticancer Res; 2017 Oct; 37(10):5507-5513. PubMed ID: 28982863
[TBL] [Abstract][Full Text] [Related]
10. Specific targeting of HER2-positive human breast carcinoma SK-BR-3 cells by amygdaline-Z
Moradipoodeh B; Jamalan M; Zeinali M; Fereidoonnezhad M; Mohammadzadeh G
Mol Biol Rep; 2020 Sep; 47(9):7139-7151. PubMed ID: 32929653
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic analysis of the antitumor efficacy of human natural killer cells against breast cancer cells.
Kajitani K; Tanaka Y; Arihiro K; Kataoka T; Ohdan H
Breast Cancer Res Treat; 2012 Jul; 134(1):139-55. PubMed ID: 22261932
[TBL] [Abstract][Full Text] [Related]
12. KIR2DL4 (CD158d) genotype influences expression and function in NK cells.
Goodridge JP; Witt CS; Christiansen FT; Warren HS
J Immunol; 2003 Aug; 171(4):1768-74. PubMed ID: 12902476
[TBL] [Abstract][Full Text] [Related]
13. Impaired natural killer cell lysis in breast cancer patients with high levels of psychological stress is associated with altered expression of killer immunoglobin-like receptors.
Varker KA; Terrell CE; Welt M; Suleiman S; Thornton L; Andersen BL; Carson WE
J Surg Res; 2007 May; 139(1):36-44. PubMed ID: 17292412
[TBL] [Abstract][Full Text] [Related]
14. IL-15 and IL-2 increase Cetuximab-mediated cellular cytotoxicity against triple negative breast cancer cell lines expressing EGFR.
Roberti MP; Barrio MM; Bravo AI; Rocca YS; Arriaga JM; Bianchini M; Mordoh J; Levy EM
Breast Cancer Res Treat; 2011 Nov; 130(2):465-75. PubMed ID: 21308409
[TBL] [Abstract][Full Text] [Related]
15. Natural killer cell activities of patients with breast cancer against different target cells.
Hamilton G; Reiner A; Teleky B; Roth E; Kolb R; Spona J; Jakesz R
J Cancer Res Clin Oncol; 1988; 114(2):191-6. PubMed ID: 3350852
[TBL] [Abstract][Full Text] [Related]
16. The genotype of the NK cell receptor, KIR2DL4, influences INFgamma secretion by decidual natural killer cells.
Goodridge JP; Lathbury LJ; John E; Charles AK; Christiansen FT; Witt CS
Mol Hum Reprod; 2009 Aug; 15(8):489-97. PubMed ID: 19509110
[TBL] [Abstract][Full Text] [Related]
17. Killer Ig-like receptor 2DL4 does not mediate NK cell IFN-γ responses to soluble HLA-G preparations.
Le Page ME; Goodridge JP; John E; Christiansen FT; Witt CS
J Immunol; 2014 Jan; 192(2):732-40. PubMed ID: 24337374
[TBL] [Abstract][Full Text] [Related]
18. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.
Yusa S; Catina TL; Campbell KS
J Immunol; 2002 May; 168(10):5047-57. PubMed ID: 11994457
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu.
Cooley S; Burns LJ; Repka T; Miller JS
Exp Hematol; 1999 Oct; 27(10):1533-41. PubMed ID: 10517495
[TBL] [Abstract][Full Text] [Related]
20. Human Leukocyte Antigen-G Inhibits the Anti-Tumor Effect of Natural Killer Cells via Immunoglobulin-Like Transcript 2 in Gastric Cancer.
Wan R; Wang ZW; Li H; Peng XD; Liu GY; Ou JM; Cheng AQ
Cell Physiol Biochem; 2017; 44(5):1828-1841. PubMed ID: 29224003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]